• DOI:10.1001/jamapsychiatry.2017.0080
Corpus ID: 28320520

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

@article{Sanacora2017ACS,
  title={A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders},
  author={G. Sanacora and M. Frye and William McDonald and S. Mathew and M. S. Turner and A. Schatzberg and P. Summergrad and C. Nemeroff},
  journal={JAMA Psychiatry},
  year={2017},
  volume={74},
  pages={399–405}
}

G. Sanacora, M. Frye, +5 authors C. Nemeroff

Published 2017

Medicine

JAMA Psychiatry

Importance Several studies now provide evidence of ketamine hydrochloride’s ability to produce rapid and robust antidepressant effects in patients with mood and anxiety disorders that were previously resistant to treatment. Despite the relatively small sample sizes, lack of longer-term data on efficacy, and limited data on safety provided by these studies, they have led to increased use of ketamine as an off-label treatment for mood and other psychiatric disorders. Observations This review and… CONTINUE READING

View on Wolters Kluwer

adaa.org

Save to Library

Create Alert

Cite

Launch Research Feed